Instituto Tecnológico y de Estudios Superiores de Monterrey, also known as Tecnológico de Monterrey or just Tec, is a secular and coeducational private university based in Monterrey, Mexico, which has grown to include 35 campuses throughout the country.

During the past decade, Instituto Tecnológico y de Estudios Superiores de Monterrey conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto Tecnológico y de Estudios Superiores de Monterrey" are "Crohn Disease" (3 trials). Many other conditions were trialed in "Instituto Tecnológico y de Estudios Superiores de Monterrey" in a lesser frequency.

Most popular intervention types in "Instituto Tecnológico y de Estudios Superiores de Monterrey" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Tecnológico y de Estudios Superiores de Monterrey" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Tecnológico y de Estudios Superiores de Monterrey". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Instituto Tecnológico y de Estudios Superiores de Monterrey, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Tecnológico y de Estudios Superiores de Monterrey, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".